Old Mission Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Old Mission Capital’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-62,983	Closed	-$884K	–	1243
2025 Q4	$884K	Buy	+62,983	New	+$883K	0.02%	453
2025 Q2	–	Sell	-261,399	Closed	-$3.45M	–	1268
2025 Q1	$3.45M	Sell	261,399 -826,399	-76%	-$11.4M	0.05%	159
2024 Q4	$17.2M	Buy	1,087,798 +1,026,778	+1,683%	+$15.4M	0.26%	34
2024 Q3	$970K	Buy	61,020 +20,550	+51%	+$331K	0.01%	494
2024 Q2	$617K	Sell	40,470 -197,215	-83%	-$2.83M	0.01%	646
2024 Q1	$3.49M	Buy	237,685 +94,650	+66%	+$1.38M	0.06%	226
2023 Q4	$1.99M	Buy	+143,035	New	+$1.91M	0.04%	345
2022 Q4	–	Sell	-120,350	Closed	-$1.26M	–	1683
2022 Q3	$1.26M	Buy	+120,350	New	+$1.28M	0.04%	341
2022 Q2	–	Sell	-73,860	Closed	-$823K	–	1724
2022 Q1	$823K	Buy	+73,860	New	+$837K	0.02%	544

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Old Mission Capital's RDY Position: Q1 2026 in Review

Old Mission Capital sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 62,983 shares — an estimated $884K sold.

Old Mission Capital first reported a position in RDY in Q1 2022 and held it in 9 quarters. The position peaked at $17.2M in Q4 2024. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Old Mission Capital reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
Old Mission Capital sold 62,983 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $884K.
Old Mission Capital first reported a position in Dr. Reddy's Laboratories in Q1 2022 and held it in 9 quarters.
Old Mission Capital's Dr. Reddy's Laboratories position peaked at $17.2M in Q4 2024.
249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Old Mission Capital's 13F filing for Q1 2026, filed 15 May 2026.